STAT December 18, 2019
WASHINGTON — The Trump administration released two highly anticipated policy documents Wednesday that, if finalized, would facilitate the importation of cheaper drugs from abroad — though both represent early first steps toward that goal.
The drafts create two pathways for importation. One would let states, drug wholesalers, or pharmacies apply to import certain drugs from Canada, pending a sign-off from the Department of Health and Human Services. A second would let drug makers import their own products sold in other countries.
Both must still undergo a formal regulatory review, a process that can take months or even longer. But the administration insists it is moving as fast as the law will allow.
“We will move as quickly as humanly possible...
Today's Sponsors
Today's Sponsor